ELMD vs SPXC vs GNRC vs INGN

For growth investors, Electromed, Inc.

(ELMD) is the stronger pick with 17. 0% revenue growth year-over-year, versus -2. 0% for Generac Holdings Inc. (GNRC). Electromed, Inc. (ELMD) offers the better valuation at 31. 2x trailing P/E (24. 4x forward), making it the more compelling value choice. Analysts rate Electromed, Inc. (ELMD) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Electromed, Inc.

(ELMD) is the cheapest at 31. 2x versus Generac Holdings Inc. at 99. 2x. On forward P/E, Electromed, Inc. is actually cheaper at 24. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: SPX Technologies, Inc. wins at 1. 37x versus Electromed, Inc. 's 1. 90x — a reasonable growth-adjusted valuation.

Over the past 5 years, SPX Technologies, Inc.

(SPXC) delivered a total return of +222. 6%, compared to -89. 2% for Inogen, Inc. (INGN). Over 10 years, the gap is even starker: SPXC returned +1183% versus INGN's -85. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Electromed, Inc.

(ELMD) is the lower-risk stock at 1. 03β versus Generac Holdings Inc. 's 1. 69β — meaning GNRC is approximately 65% more volatile than ELMD relative to the S&P 500. On balance sheet safety, Electromed, Inc. (ELMD) carries a lower debt/equity ratio of 0% versus 51% for Generac Holdings Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Electromed, Inc.

(ELMD) is pulling ahead at 17. 0% versus -2. 0% for Generac Holdings Inc. (GNRC). On earnings-per-share growth, the picture is similar: Electromed, Inc. grew EPS 48. 3% year-over-year, compared to -50. 1% for Generac Holdings Inc.. Over a 3-year CAGR, SPXC leads at 15. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Electromed, Inc.

(ELMD) is the more profitable company, earning 11. 8% net margin versus -6. 5% for Inogen, Inc. — meaning it keeps 11. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SPXC leads at 16. 8% versus -8. 7% for INGN. At the gross margin level — before operating expenses — ELMD leads at 78. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, SPX Technologies, Inc. (SPXC) is the more undervalued stock at a PEG of 1. 37x versus Electromed, Inc. 's 1. 90x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Electromed, Inc. (ELMD) trades at 24. 4x forward P/E versus 30. 9x for Generac Holdings Inc. — 6. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for INGN: 261. 6% to $26. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, SPX Technologies, Inc.

(SPXC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1183% 10Y return). Generac Holdings Inc. (GNRC) carries a higher beta of 1. 69 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SPXC: +1183%, GNRC: +666. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ELMD (Healthcare) and SPXC (Industrials) and GNRC (Industrials) and INGN (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ELMD is a small-cap high-growth stock; SPXC is a mid-cap quality compounder stock; GNRC is a mid-cap quality compounder stock; INGN is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.